MiNK Therapeutics
INKT
INKT
24 hedge funds and large institutions have $1.7M invested in MiNK Therapeutics in 2025 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
24
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$443K | |
| 2 | +$332K | |
| 3 | +$50.4K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$18.6K |
| 5 |
Citigroup
New York
|
+$4.35K |
Top Sellers
| 1 | -$54.2K | |
| 2 | -$8.15K | |
| 3 | -$1.23K | |
| 4 |
Morgan Stanley
New York
|
-$142 |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$90 |
